首頁
Shilpa Biologicals

7月 2026Shilpa Biologicals的市場佔有率分析

An end-to-end biopharmaceutical company in India, Shilpa Biologicals delivers WHO-GMP biologics manufacturing and affordable products built to global standards.

行業: N/A

域名shilpabio.com

成立年份2007

僱員201 - 500

年度營收--

Shilpa Biologicals

Shilpa Biologicals（包含公司地區）

shilpabio.com

查看更多網站流量與參與度資訊

Shilpa Biologicals的熱門網域總造訪量

了解Shilpa Biologicals市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

shilpabio.com1.2K

透過銷售情報查看更多內容

Shilpa Biologicals的熱門網域平均造訪時長

分析Shilpa Biologicals參與度指標。

過去 3 個月平均造訪時長

子公司細目

shilpabio.com00:01:06

透過銷售情報查看更多內容

Shilpa Biologicals的熱門網域平均頁面瀏覽量

了解Shilpa Biologicals如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

shilpabio.com2.19

透過銷售情報查看更多內容

Shilpa Biologicals按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術Shilpa Biologicals

这些是Shilpa Biologicals顶级域名使用的行业网站技术

小工具 (6)

Twemoji

付費廣告 (3)

PubMatic

內容管理系統 (3)

WordPress

轉換與分析 (2)

Google Analytics

更多技術

6

檢視所有

新聞與訊號來自Shilpa Biologicals

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Shilpa Biologicals Private Limited hired Uday N. Harle as Chief Executive Officer on Aug 3rd '26.Shilpa Medicare has announced the appointment of Dr Uday N. Harle as the Chief Executive Officer (CEO) of Shilpa Biologicals, its wholly owned subsidiary.

新聞Shilpabio expanded facilities to India, Southern Asia, Asia on Jul 29th '26.Integrated ADC production site launched in India by Shilpa Biologics.

新聞Shilpabio is developing nivolumab biosimilar on Jul 6th '26.Dharwad (Karnataka) [India], July 6: Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world's most widely used cancer immunotherapies to widen patient access across Europe.